Company intelligence / Profile preview

TowerBrook Capital Partners

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

TowerBrook Capital Partners is a transatlantic investment firm focused on private equity, structured opportunities, and impact investments. With over $23 billion in assets under management (AUM) as of 2025, it is recognized as the first mainstream private equity firm to earn B Corporation certification in 2019. While primarily an investment firm and not a direct life sciences/biotech/pharma operator, TowerBrook is a significant investor in healthcare and related sectors, with notable portfolio companies including R1 RCM and Compassus.

Industry: Investors

Partnerships

Clayton, Dubilier & RiceAscension Health

Beyond the preview

Go deeper on TowerBrook Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TowerBrook Capital Partners.

Explore the full profile